(Q38808625)

6 September 2017

title

Plerixafor is safe and efficacious for mobilization of peripheral blood stem cells in pediatric patients (English)

1 reference

6 September 2017

Ashley Teusink

1

1 reference

6 September 2017

Susan Pinkard

2

1 reference

6 September 2017

Stella Davies

3

1 reference

6 September 2017

Mark Mueller

4

1 reference

6 September 2017

Sonata Jodele

5

1 reference

6 September 2017

publication date

15 April 2016

1 reference

6 September 2017

1 reference

6 September 2017

volume

56

1 reference

6 September 2017

issue

6

1 reference

6 September 2017

page(s)

1402-1405

1 reference

Systematic review of randomized controlled trials of hematopoietic stem cell mobilization strategies for autologous transplantation for hematologic malignancies

6 September 2017

cites work

1 reference

Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial

21 January 2018

1 reference

Diagnostic features, treatment, and outcomes of Takayasu arteritis in a US cohort of 126 patients

21 January 2018

1 reference

Phase III prospective randomized double-blind placebo-controlled trial of plerixafor plus granulocyte colony-stimulating factor compared with placebo plus granulocyte colony-stimulating factor for autologous stem-cell mobilization and transplantatio

21 January 2018

1 reference

Plerixafor on-demand combined with chemotherapy and granulocyte colony-stimulating factor: significant improvement in peripheral blood stem cells mobilization and harvest with no increase in costs.

21 January 2018

1 reference

Physiology and pharmacology of plerixafor

21 January 2018

1 reference

Phase I study of the safety and pharmacokinetics of plerixafor in children undergoing a second allogeneic hematopoietic stem cell transplantation for relapsed or refractory leukemia.

21 January 2018

1 reference

Mobilization of hematopoietic stem cells by plerixafor alone in children: a sequential Bayesian trial.

21 January 2018

1 reference

A pilot study evaluating the safety and CD34+ cell mobilizing activity of escalating doses of plerixafor in healthy volunteers

21 January 2018

1 reference

Plerixafor plus G-CSF in combination with chemotherapy for stem cell mobilization in a pediatric patient with Ewing's sarcoma.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/TRF.13599

1 reference

6 September 2017

1 reference